Loading…
Tissue-resident memory T cells in the skin
Purpose Tissue-resident memory T (T RM ) cells are a newly described subset of memory T cells. The best characterized T RM cells are CD8+ and express CD103 and CD69. These cells are non-recirculating and persist long term in tissues, providing immediate protection against invading pathogens. However...
Saved in:
Published in: | Inflammation research 2020-03, Vol.69 (3), p.245-254 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose
Tissue-resident memory T (T
RM
) cells are a newly described subset of memory T cells. The best characterized T
RM
cells are CD8+ and express CD103 and CD69. These cells are non-recirculating and persist long term in tissues, providing immediate protection against invading pathogens. However, their inappropriate activation might contribute to the pathogenesis of autoimmune and inflammatory disorders. In the skin, these cells have been described in psoriasis, vitiligo, and melanoma among other diseases.
Methods
Literature review was done to highlight what is currently known on the phenotype and function of T
RM
cells and summarizes the available data describing their role in various cutaneous conditions.
Results
Resolved psoriatic skin and disease-naïve non-lesional skin contain a population of IL-17-producing T
RM
cells with shared receptor sequences that recognize common antigens and likely contribute to disease recurrence after cessation of therapy. In vitiligo, T
RM
cells produce perforin, granzyme B, and interferon-γ following stimulation by interleukin-15 and collaborate with recirculating memory T cells to maintain disease. In melanoma, increased accumulation of T
RM
cells was recently shown to correlate with improved survival in patients undergoing therapy with immune checkpoint inhibitors. |
---|---|
ISSN: | 1023-3830 1420-908X |
DOI: | 10.1007/s00011-020-01320-6 |